| URL | https://www.msn.com/en-us/money/markets/gilead-ann |
| Source | MSN |
| Date Published | 05/07/2025 |
| Author Name | Christy Santhosh |
| Company/Division name | Gilead Sciences Inc. |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2025 |
| Capital investment ($): | 3200 |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharmaceuticals |
| What non-domestic negative factors made offshoring less attractive? | Tariffs |
| What domestic positive factors made reshoring more attractive? | Manufacturing/engineering joint innovation (R&D), Proximity to customers/market |